Abstract
The accumulation of IP injected 3H-desipramine (DMI) in the brain and in the liver has been studied in both male and female rats. The total amount of DMI in the brains of females is 2 to 4 times that found in the brains of males. In females the amount of DMI is highest on the day of estrus and lowest on proestrus. This sex difference was not found following the injections of another psychoactive drug, 3H-chlorpromazine. In both males and females the level of DMI in the cortex and caudate is slightly higher than in the hippocampus, septum and hypothalamus. The pharmaco-kinetics and dose dependence of the accumulation of DMI are also similar in males and females. Maximal levels are reached in the liver in less than 15 min, whereas in the brain it takes 30 min. The decline of radioactivity in the liver is faster than in brain. There is no saturation in the amount of DMI taken up in brain or liver in the dose range up to 40 mg/kg. The sex difference in the amount of 3H-DMI in brain, which may be the result of sex-dependent metabolism in liver microsomes, may explain the male-female differences in reaction to antidepressants.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alfredsson, G., Wiesel, F. A., Skett, P.: Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion. Psychopharmacology 53, 13–18 (1977)
Asberg, M., Cronholm, B., Sjoqvist, F., Tuck, D.: Relationship between plasma level and therapeutic effect of nortriptyline. Br. Med. J. 3, 331–334 (1971)
Bickel, M. H., Mider, R.: Metabolism and biliary excretion of the lipophilic drug molecules, imipramine and desmethylimipramine, in the rat-1. Biochem. Pharmacol. 19, 2425–2435 (1970)
Fuxe, K., Ogren, S. O., Agnati, L., Gustatsson, J. A., Jonsson, G.: On the mechanism of action of the antidepressant drugs amitriptyline and protriptyline. Evidence for 5-hydroxytryptamine receptor blocking activity. Neuroscience Letters 6, 339–343 (1977)
Gram, L. F.: Factors influencing the metabolism of tricyclic antidepressants. Dan. Med. Bul. 24, 81–89 (1977)
Gram, T. E., Gillette, J. R.: Biotransformation of drugs. In: Fundamentals of biochemical pharmacology, Z. M. Bacq, ed., pp. 571–609 Oxford, New York: Pergamon 1971
Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Ransil, B. J., Koch-Weser, J.: Kinetics of intravenous chlordiazepoxide: Sex differences in drug distribution. Clin. Pharm. Ther. 22, 893–903 (1977)
Hammer, W., Sjoqvist, F.: Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sci. 6, 1895–1903 (1967)
Jori, A., Bernardi, D., Muscettola, G., Garattini, S.: Brain levels of imipramine and desipramine after combined treatment with these drugs in rats. Eur. J. Pharmacol. 15, 85–90 (1971)
Kragh-Sorensen, P., Eggert Hansen, C., Baastrup, P. C., Huidberg, E. F.: Self inhibiting action of nortriptyline's antidepressive effect at high plasma levels. Psychopharmacologia 45, 305–312 (1976)
Kwant, W. O., Seeman, P.: Chlorpromazine adsorption to brain regions. Biochem. Pharmacol. 20, 2089–2091 (1971)
Ladurn, P., Leysen, J.: Specific in vivo binding of neuroleptic drugs in rat brain. Biochem. Pharmacol. 26, 1003–1007 (1977)
Moody, J. P., Tait, A. C., Todrick, A.: Plasma levels of imipramine and desmethylimipramine during therapy. Brit. J. Psychiat. 113, 183–193 (1967)
Nagy, A., Treiber, L.: Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin layer chromatograms. J. Pharm. Pharmac. 25, 599–603 (1973)
Pscheidt, G. E.: Demethylation of imipramine in male and female rats. Biochem. Pharmacol. 11, 501–503 (1962)
Quinn, G. P., Axelrod, J., Brodie, B. B.: Species strain and sex differences in metabolism of hexobarbitone, aminopyrine, antipyrine and aniline. Biochem. Pharmacol. 1, 152–159 (1958)
Raskin, A.: Age-sex differences in response to antidepressant drugs. J. Nerv. Ment. Dis. 159, 120–130 (1974)
Rechavi, M., Sokolovsky, M.: Multiple binding sites of tricyclic antidepressants drugs to mammalian brain receptors. Brain Res. 149, 525–529 (1978)
Schenkman, J. B., Frey, I., Remmer, H., Eastbrods, W.: Sex differences in drug metabolism by rat liver microsomes. Mol. Pharmacol. 3, 516–525 (1967)
Shani, J., Givant, Y., Sulman, F. G., Eylath, U., Eckstein, B.: Competition of phenothiazines with estradiol for oestradiol receptors in rat brain. Neuroendocrinology 8, 307–316 (1971)
U'Prichard, D. C., Greenberg, D. A., Sheehan, P. P., Snyder, S. H.: Tricyclic antidepressants: Therapeutic properties and affinity for α-noradrenergic receptor binding sites in the brain. Science 199, 197–198 (1978)
Wiesel, F. A., Alfredsson, G.: The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism. Eur. J. Pharmacol. 40, 263–272 (1976)
Wilson, I. C., Robon, A. M., Buffaloe, W. J.: Imipramine therapy in depressive syndromes: Prediction of therapeutic outcome. Psychosomatics 8, 203–207 (1967)
Wirz-Justice, A., Chappuis-Arndt, E.: Sex specific differences in chlorimipramine inhibition of serotonin uptake in human platelets. Eur. J. Pharmacol. 40, 21–25 (1976)
Wirz-Justice, A., Lichtsteiner, M.: Sex specific differences is noradrenaline uptake and its inhibition by maprotiline. J. Pharm. Pharmacol 28, 172–174 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Biegon, A., Samuel, D. The in vivo distribution of an antidepressant drug (DMI) in male and female rats. Psychopharmacology 65, 259–263 (1979). https://doi.org/10.1007/BF00492213
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00492213